BaroFold Inc., a Boulder, Colo.-based developer of protein therapeutics, has raised $12 million in Series A funding. HBM BioVentures and Boulder Ventures co-led the deal, and were joined by seed backers like the Peierls Foundation. www.barofold.com
BaroFold Inc., a Boulder, Colo.-based developer of protein therapeutics, has raised $12 million in Series A funding. HBM BioVentures and Boulder Ventures co-led the deal, and were joined by seed backers like the Peierls Foundation. www.barofold.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.